Covered recipient · General Payments record
KEITH MORTMAN
Allopathic & Osteopathic Physicians Thoracic Surgery (Cardiothoracic Vascular Surgery)
General Payments · PY2018–2024
$253,142.15
- Reported across 304 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $5,176.25 | 2 |
| Food and Beverage | $1,610.06 | 14 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Ethicon Inc. | $4,671.25 | 1 |
| Ethicon US, LLC | $1,104.66 | 6 |
| Acerta Pharma LLC | $247.16 | 2 |
| GENZYME CORPORATION | $237.92 | 2 |
| GlaxoSmithKline, LLC. | $178.12 | 1 |
| DAVOL INC. | $163.28 | 1 |
| Grifols USA, LLC | $133.10 | 1 |
| Medtronic, Inc. | $50.82 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $116.02 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104692864 | CMS |
| AstraZeneca Pharmaceuticals LP | $131.14 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105566560 | CMS |
| Davol Inc. | $163.28 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127646015 | CMS |
| Ethicon Inc. | $4,671.25 | 05/02/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1077586358 | CMS |
| Ethicon US, LLC | $131.56 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077627108 | CMS |
| Ethicon US, LLC | $505.00 | 04/01/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1077652150 | CMS |
| Ethicon US, LLC | $140.89 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077627188 | CMS |
| Ethicon US, LLC | $130.55 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077627098 | CMS |
| Ethicon US, LLC | $94.15 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077627080 | CMS |
| Ethicon US, LLC | $102.51 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077627142 | CMS |
| GENZYME CORPORATION | $118.22 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139943493 | CMS |
| GENZYME CORPORATION | $119.70 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139943533 | CMS |
| GlaxoSmithKline, LLC. | $178.12 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116573598 | CMS |
| Grifols USA, LLC | $133.10 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124718058 | CMS |
| Medtronic, Inc. | $26.00 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117126164 | CMS |
| Medtronic, Inc. | $24.82 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117126166 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.